Synchronized Core-Pelvic Floor Activation in Urinary Incontinence

February 4, 2026 updated by: Betül Çınar, Bezmialem Vakif University

Synchronized Activation of Core and Pelvic Floor Muscles: A More Effective Strategy for Urinary Incontinence?

This study aims to investigate whether co-activation of the pelvic floor and core muscles improves treatment outcomes in individuals with urinary incontinence. Participants diagnosed with stress, or mixed urinary incontinence will undergo a 12-week pelvic floor physiotherapy program, with or without additional core muscle co-activation exercises. Changes in urinary incontinence severity, pelvic floor muscle function, core muscle activation, and quality of life will be evaluated.

Study Overview

Detailed Description

Urinary incontinence is a prevalent condition that negatively affects quality of life and functional independence. Pelvic floor muscle training (PFMT) is recommended as a first-line conservative treatment. Recent evidence suggests that coordinated activation of the pelvic floor muscles with core muscles, including the transversus abdominis and multifidus, may enhance treatment effectiveness.

This randomized controlled study will include women aged 18-65 years diagnosed with stress or mixed urinary incontinence. Eligible participants will be randomly allocated to one of two groups: a conventional pelvic floor muscle training group (control group) or a pelvic floor muscle training plus core muscle co-activation group (intervention group).

Both groups will participate in a 12-week exercise program performed at least three days per week, including one supervised session and two home-based sessions weekly. Outcome measures will be assessed at baseline and after completion of the intervention. Primary outcomes include urinary incontinence severity, while secondary outcomes include pelvic floor muscle function, core muscle activation assessed by surface electromyography, and quality of life.

Study Type

Interventional

Enrollment (Estimated)

50

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Aged between 18 and 65 years
  • Diagnosed with stress, urge, or mixed urinary incontinence
  • Pelvic floor muscle strength grade ≥ 3 according to the Modified Oxford Scale
  • At least one episode of urinary leakage within the last month

Exclusion Criteria:

  • Pregnancy
  • Childbirth within the previous 6 weeks
  • Severe pelvic organ prolapse
  • Active vaginal or urinary tract infection
  • Presence of neurological or psychiatric disorders
  • Malignancy
  • Inability to cooperate with assessments or interventions

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Pelvic floor muscle training
Participants will receive conventional pelvic floor muscle training for 12 weeks, at least three days per week
Participants will receive conventional pelvic floor muscle training based on standardized pelvic floor physiotherapy principles. Exercises will be performed for 12 weeks, at least three days per week, including one supervised session and two home-based sessions.
Experimental: Synchronized Core-Pelvic Floor Muscle Training
Participants will receive pelvic floor muscle training combined with co-activation exercises targeting core muscles for 12 weeks at least three days per week
Participants will receive pelvic floor muscle training combined with co-activation exercises targeting core muscles. The program will be conducted for 12 weeks with the same frequency and supervision structure as the control group.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
International Consultation on Incontinence Questionnaire
Time Frame: 12 weeks

This is a brief patient-reported questionnaire used to assess the frequency, severity, and impact of urinary incontinence on quality of life.

Minimum Score: 0

Maximum Score: 21

Interpretation: Higher scores indicate worse symptoms and a greater impact on quality of life.

Breakdown: The score is the sum of three items: frequency (0-5), amount (0-6), and interference with everyday life (0-10).

12 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Surface electromyography
Time Frame: 12 weeks
This is used to evaluate Core and Pelvic Floor Muscle Activation
12 weeks
PERFECT scheme
Time Frame: 12 weeks
This is used to evaluate Pelvic Floor Muscle Function. It evaluates four components: Power, Endurance, Repetitions, and Fast contractions. Higher scores indicate better muscle function
12 weeks
Urogenital Distress Inventory (UDI-6)
Time Frame: 12 weeks

This questionnaire assesses the degree of bother associated with specific urogenital symptoms (e.g., frequent urination, leakage).

Minimum Score: 0

Maximum Score: 100 (Standardized Scale)

Interpretation: Higher scores indicate worse quality of life (higher distress).

Calculation: There are 6 items. Each is rated 0 (Not at all) to 3 (Greatly). The average score of the items is calculated and then multiplied by 33.33 to convert it to a 0-100 scale.

12 weeks
the Incontinence Impact Questionnaire (IIQ-7)
Time Frame: 12 weeks

This questionnaire measures the impact of urinary incontinence on activities, roles, and emotional health.

Minimum Score: 0

Maximum Score: 100 (Standardized Scale)

Interpretation: Higher scores indicate worse quality of life (greater negative impact).

Calculation: There are 7 items. Each is rated 0 (Not at all) to 3 (Greatly). Like the UDI-6, the average of the item scores is multiplied by 33.33 to obtain the final 0-100 score.

12 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Betül Çınar, Bezmialem.edu.tr

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

January 30, 2026

Primary Completion (Estimated)

June 30, 2026

Study Completion (Estimated)

August 30, 2026

Study Registration Dates

First Submitted

January 28, 2026

First Submitted That Met QC Criteria

January 28, 2026

First Posted (Actual)

February 4, 2026

Study Record Updates

Last Update Posted (Actual)

February 6, 2026

Last Update Submitted That Met QC Criteria

February 4, 2026

Last Verified

February 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Urinary Incontinence

Clinical Trials on Conventional Pelvic Floor Muscle Training

Subscribe